Rankings
▼
Calendar
PRGO Q4 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q4 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
-2.5% YoY
Gross Profit
$362M
32.6% margin
Operating Income
$85M
7.6% margin
Net Income
-$1.4B
-127.8% margin
EPS (Diluted)
$-10.23
QoQ Revenue Growth
+6.4%
Cash Flow
Operating Cash Flow
$175M
Free Cash Flow
$149M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$8.5B
Total Liabilities
$5.6B
Stockholders' Equity
$2.9B
Cash & Equivalents
$532M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.1B
-2.5%
Gross Profit
$362M
$386M
-6.1%
Operating Income
$85M
$114M
-25.8%
Net Income
-$1.4B
-$45M
-3086.7%
Revenue Segments
Consumer Self-Care Americas
$697M
63%
Consumer Self-Care International
$413M
37%
Geographic Segments
UNITED STATES
$685M
61%
Europe
$398M
35%
Other Geographical Areas
$27M
2%
IRELAND
$13M
1%
← FY 2025
All Quarters